(Q50687479)

English

High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.

scientific article published on 21 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Gilberto de Castro

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Igor Moisés Longo Snitcovsky

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Eloísa Maria Mello Santiago Gebrim

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Glauber Moreira Leitão

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Wladimir Nadalin

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Alberto Rossetti Ferraz

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

Miriam Hatsue Honda Federico

7

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

publication date

21 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

European Archives of Oto-Rhino-Laryngology

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

264

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

12

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

1475-1482

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

https://scigraph.springernature.com/pub.10.1007/s00405-007-0395-9

0 references

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing new chemoradiation regimens for head-and-neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Target coverage for head and neck cancers treated with IMRT: review of clinical experiences

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17643256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00405-007-0395-9

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17643256

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50687479&oldid=1584439082"